Donald Woods has been named senior vice president of Biolink (Middleboro, Massachusetts), a developer of vascular access systems for hemodialysis. Most recently Woods was president of the Medi-Tech Division of Boston Scientific. Additionally, Timothy Costello was named vice president of marketing for the company, and Adrian Ravenscroft will become the firm's engineering programs manager. Albert Kelley, has been promoted from vice president of sales and marketing to vice president, international. Most recently, Costello was vice president of worldwide marketing for Candela. Previously, Ravenscroft was program manager and senior R&D engineer at NMT Medical.

Toby Thomas has been named chief financial officer of Corvascular (Palo Alto, California). Thomas previously was vice president, finance, with Vivra. Corvascular is a privately held company developing technologies for improving cardiac surgery.

Willard Henneman, PhD, has been named vice president of research and development for CryoCath Technologies (Kirkland, Quebec, Canada), effective next month. He will be responsible for all R&D programs in the areas of electrophysiology and interventional cardiology. Previously, he has been with Cordis, Medtronic and Datascope.

Brad Nutter has been appointed president of Gambro Healthcare (Stockholm, Sweden), replacing Mats Wahlstrom, who will leave the company to pursue other opportunities. Nutter previously was executive vice president and chief operating officer of Syncor.

Christopher Cerone has been named director of global strategy and analysis for Europe at the Health Industry Manufacturers Association (Washington). Most recently, Cerone was a senior associate in global economic affairs for Eli Lilly and Co.

Ronald Rinaldi has been promoted from director of software architecture to vice president of product development for Healthgate Data (Burlington, Massachusetts). Healthgate is developing a web platform for hospitals and other health care institutions.

Peter Charalambous, PhD, has been named director of marketing and sales for the Cardiopulmonary Systems Group at Meridian Medical Technologies (Columbia, Maryland). He will be responsible for the introduction of the company's Prime ECG electrocardiac mapping system on a worldwide basis. The diagnostic device will be launched in major countries in Europe this year following receipt of the CE Mark in 1999. Clinical trials on the system are being conducted at the Medical College of Virginia in preparation for a filing with the FDA for marketing approval. Charalambous previously was director of sales, North America, at Applied Imaging.